Advertisement
Singapore markets close in 31 minutes
  • Straits Times Index

    3,273.86
    -13.89 (-0.42%)
     
  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • FTSE 100

    8,115.73
    +36.87 (+0.46%)
     
  • Bitcoin USD

    64,346.65
    +352.70 (+0.55%)
     
  • CMC Crypto 200

    1,389.40
    -7.14 (-0.51%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • Dow

    38,085.80
    -375.12 (-0.98%)
     
  • Nasdaq

    15,611.76
    -100.99 (-0.64%)
     
  • Gold

    2,358.10
    +15.60 (+0.67%)
     
  • Crude Oil

    83.85
    +0.28 (+0.34%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • FTSE Bursa Malaysia

    1,573.28
    +4.03 (+0.26%)
     
  • Jakarta Composite Index

    7,055.28
    -100.01 (-1.40%)
     
  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

3 Reasons Pfizer Stock Will Crush the Broader Market in 2023

3 Reasons Pfizer Stock Will Crush the Broader Market in 2023

Pfizer (NYSE: PFE) is a 173-year-old company with a huge portfolio of products. This year, Pfizer has dropped about 16%, in line with the S&P 500. In fact, there are three reasons Pfizer stock could crush the broader market in 2023.